These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 37392464)

  • 41. Digital therapeutics in the clinic.
    Phan P; Mitragotri S; Zhao Z
    Bioeng Transl Med; 2023 Jul; 8(4):e10536. PubMed ID: 37476062
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Digital Therapeutics: Emerging New Therapy for Nonalcoholic Fatty Liver Disease.
    Zhou R; Gu Y; Zhang B; Kong T; Zhang W; Li J; Shi J
    Clin Transl Gastroenterol; 2023 Apr; 14(4):e00575. PubMed ID: 36854062
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Exercise therapy as a digital therapeutic for chronic disease management: consideration for clinical product development.
    Grannell A; Hallson H; Gunlaugsson B; Jonsson H
    Front Digit Health; 2023; 5():1250979. PubMed ID: 38173910
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ethics of digital therapeutics (DTx).
    Refolo P; Sacchini D; Raimondi C; Spagnolo AG
    Eur Rev Med Pharmacol Sci; 2022 Sep; 26(18):6418-6423. PubMed ID: 36196692
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical Pharmacology of RNA Interference-Based Therapeutics: A Summary Based on Food and Drug Administration-Approved Small Interfering RNAs.
    Jing X; Arya V; Reynolds KS; Rogers H
    Drug Metab Dispos; 2023 Feb; 51(2):193-198. PubMed ID: 36332914
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy and safety of digital therapeutics-based cardiac rehabilitation in heart failure patients: a systematic review.
    Zhang X; Luo Z; Yang M; Huang W; Yu P
    ESC Heart Fail; 2022 Dec; 9(6):3751-3760. PubMed ID: 36085358
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Changing face of healthcare: digital therapeutics in the management of diabetes.
    Ramakrishnan P; Yan K; Balijepalli C; Druyts E
    Curr Med Res Opin; 2021 Dec; 37(12):2089-2091. PubMed ID: 34511002
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Digital Therapeutics in Migraine Management: A Novel Treatment Option in the COVID-19 Era.
    Chen X; Luo Y
    J Pain Res; 2023; 16():111-117. PubMed ID: 36660558
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects on Adherence to a Mobile App-Based Self-management Digital Therapeutics Among Patients With Coronary Heart Disease: Pilot Randomized Controlled Trial.
    Li Y; Gong Y; Zheng B; Fan F; Yi T; Zheng Y; He P; Fang J; Jia J; Zhu Q; Jiang J; Huo Y
    JMIR Mhealth Uhealth; 2022 Feb; 10(2):e32251. PubMed ID: 34906924
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Exploring the Category and Use Cases on Digital Therapeutic Methodologies.
    An S; Ko J; Yu KS; Kwon H; Kim S; Hong J; Kong HJ
    Healthc Inform Res; 2023 Jul; 29(3):190-198. PubMed ID: 37591674
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Potential effectiveness of digital therapeutics specialized in executive functions as adjunctive treatment for clinical symptoms of attention-deficit/hyperactivity disorder: a feasibility study.
    Sun TH; Yeom JW; Choi KY; Kim JL; Lee HJ; Kim HJ; Cho CH
    Front Psychiatry; 2023; 14():1169030. PubMed ID: 37547212
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Assessing the Potential Risks of Digital Therapeutics (DTX): The DTX Risk Assessment Canvas.
    Denecke K; May R; Gabarron E; Lopez-Campos GH
    J Pers Med; 2023 Oct; 13(10):. PubMed ID: 37888134
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Digital therapeutics and the need for regulation: how to develop products that are innovative, patient-centric and safe.
    Rassi-Cruz M; Valente F; Caniza MV
    Diabetol Metab Syndr; 2022 Apr; 14(1):48. PubMed ID: 35365189
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Digital Therapeutics: Health Care Wired for the Future.
    Kaldy J
    Sr Care Pharm; 2020 Aug; 35(8):338-344. PubMed ID: 32718389
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Meta-Analysis of Studies on the Effects of Digital Therapeutics.
    Seo YC; Yong SY; Choi WW; Kim SH
    J Pers Med; 2024 Jan; 14(2):. PubMed ID: 38392592
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The scientific basis of rational prescribing. A guide to precision clinical pharmacology based on the WHO 6-step method.
    Rongen GA; Marquet P; van Gerven JMA;
    Eur J Clin Pharmacol; 2021 May; 77(5):677-683. PubMed ID: 33210160
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Analysis of the Status and Future Direction for Digital Therapeutics in Children and Adolescent Psychiatry.
    Choi H; Kim B; Kim I; Kang JG; Lee Y; Lee H; Park MH
    Soa Chongsonyon Chongsin Uihak; 2023 Oct; 34(4):192-203. PubMed ID: 37841489
    [TBL] [Abstract][Full Text] [Related]  

  • 59. What drives patients' acceptance of Digital Therapeutics? Establishing a new framework to measure the interplay between rational and institutional factors.
    Carrera A; Zoccarato F; Mazzeo M; Lettieri E; Toletti G; Bertoli S; Castelnuovo G; Fresa E
    BMC Health Serv Res; 2023 Feb; 23(1):145. PubMed ID: 36765410
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical pharmacology: Current innovations and future challenges.
    Cracowski JL; Hulot JS; Laporte S; Charvériat M; Roustit M; Deplanque D; Girodet PO;
    Fundam Clin Pharmacol; 2022 Jun; 36(3):456-467. PubMed ID: 34954839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.